Vivimed Labs has informed that a meeting of the Board of Directors of the Company will be held on January 11, 2016, to consider the sub division of equity shares of Rs 10 each into shares with lower face value. In this connection as per the Company’s codes of Fair Disclosure & Conduct adopted pursuant to SEBI (Prohibition of Insider Trading) Regulation, 2015, the trading window of The Company will be closed for all insiders as mentioned in the above said code of Fair Disclosure and Conduct of the company with immediate effect and shall be opened 48 hours alter the intimation of outcome of above said Board Meeting to Stock Exchanges. This intimation regarding closure of Trading Window shall be communicated to all the insiders of the Company.
The above information is a part of company’s filings submitted to BSE.
| Company Name | CMP |
|---|---|
| Sun Pharma Inds. | 1847.30 |
| Dr. Reddys Lab | 1293.25 |
| Cipla | 1347.70 |
| Zydus Lifesciences | 938.90 |
| Lupin | 2377.90 |
| View more.. | |
MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.
To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.
MoneyWorks4Me ensures this through: